PAX1
Basic information
Region (hg38): 20:21705659-21718481
Links
Phenotypes
GenCC
Source:
- otofaciocervical syndrome 2 (Limited), mode of inheritance: AD
- otofaciocervical syndrome 2 (Definitive), mode of inheritance: AR
- otofaciocervical syndrome 2 (Strong), mode of inheritance: AR
- otofaciocervical syndrome 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Otofaciocervical syndrome 2, with T-cell deficiency | AR | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; The condition has been described as including thymic anomalies and T-cell immunodeficiency associated with severe infections, and awareness may allow preventative measures and early and aggressive management of infections | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic | 23851939; 28657137; 29681087; 32111619 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (357 variants)
- Inborn_genetic_diseases (87 variants)
- Otofaciocervical_syndrome_2 (21 variants)
- PAX1-related_disorder (10 variants)
- not_specified (6 variants)
- Craniofacial_microsomia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAX1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001257096.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 127 | 4 | 140 | ||
| missense | 2 | 2 | 190 | 14 | 2 | 210 |
| nonsense | 3 | 4 | 1 | 8 | ||
| start loss | 0 | |||||
| frameshift | 7 | 8 | 1 | 16 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 12 | 16 | 201 | 141 | 6 |
Highest pathogenic variant AF is 0.0003927273
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PAX1 | protein_coding | protein_coding | ENST00000398485 | 5 | 10324 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125571 | 0 | 4 | 125575 | 0.0000159 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.758 | 305 | 270 | 1.13 | 0.0000129 | 3303 |
| Missense in Polyphen | 83 | 95.948 | 0.86505 | 1136 | ||
| Synonymous | -2.44 | 154 | 120 | 1.28 | 0.00000593 | 1203 |
| Loss of Function | 2.77 | 2 | 12.6 | 0.158 | 5.51e-7 | 152 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000545 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000181 | 0.0000176 |
| Middle Eastern | 0.0000545 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: This protein is a transcriptional activator. It may play a role in the formation of segmented structures of the embryo. May play an important role in the normal development of the vertebral column (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Otofaciocervical syndrome 2 (OTFCS2) [MIM:615560]: A disorder characterized by facial dysmorphism, cup-shaped low-set ears, preauricular fistulas, hearing loss, branchial defects, skeletal anomalies including vertebral defects, low-set clavicles, winged scapulae, sloping shoulders, and mild intellectual disability. {ECO:0000269|PubMed:23851939}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.302
Intolerance Scores
- loftool
- 0.182
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.37
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.896
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Zebrafish Information Network
- Gene name
- pax1b
- Affected structure
- fin bud
- Phenotype tag
- abnormal
- Phenotype quality
- hypoplastic
Gene ontology
- Biological process
- skeletal system development;somitogenesis;transcription by RNA polymerase II;cell population proliferation;CD4-positive, alpha-beta T cell differentiation;CD8-positive, alpha-beta T cell differentiation;positive regulation of transcription by RNA polymerase II;thymus development;parathyroid gland development;bone morphogenesis;sclerotome development
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific